Abstract
TPS9111Background: LYC-55716 is a first-in-class oral, small-molecule agonist of the retinoic acid receptor–related orphan receptor γ (RORγ) being developed as an immuno-oncology agent for solid tu...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
